Annual Total Long Term Liabilities
$0.00
-$162.30 K-100.00%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual total long term liabilities is $0.00, with the most recent change of -$162.30 thousand (-100.00%) on December 1, 2023.
- During the last 3 years, BRTX annual total long term liabilities has fallen by -$4.63 million (-100.00%).
- BRTX annual total long term liabilities is now -100.00% below its all-time high of $4.63 million, reached on December 31, 2020.
Performance
BRTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly total long term liabilities is $0.00, unchanged on September 1, 2024.
- Over the past year, BRTX quarterly long term liabilities has dropped by -$42.40 thousand (-100.00%).
- BRTX quarterly long term liabilities is now -100.00% below its all-time high of $15.17 million, reached on June 30, 2020.
Performance
BRTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BRTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -100.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
BRTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
BioRestorative Therapies Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $42.40 K(-49.3%) |
| Jun 2023 | - | $83.60 K(-32.3%) |
| Mar 2023 | - | $123.50 K(-23.9%) |
| Dec 2022 | $162.30 K(-67.1%) | $162.30 K(-18.3%) |
| Sep 2022 | - | $198.70 K(-15.1%) |
| Jun 2022 | - | $234.10 K(-12.8%) |
| Mar 2022 | - | $268.40 K(-45.5%) |
| Dec 2021 | $492.70 K(-89.4%) | $492.70 K(-92.0%) |
| Sep 2021 | - | $6.18 M(+15.2%) |
| Jun 2021 | - | $5.37 M(+5.2%) |
| Mar 2021 | - | $5.10 M(+10.1%) |
| Dec 2020 | $4.63 M(+787.9%) | $4.63 M(-69.4%) |
| Sep 2020 | - | $15.15 M(-0.2%) |
| Jun 2020 | - | $15.17 M(+2948.6%) |
| Mar 2020 | - | $497.70 K(-4.6%) |
| Dec 2019 | $521.90 K(-9.8%) | $521.90 K(+204.3%) |
| Sep 2019 | - | $171.50 K(-25.9%) |
| Jun 2019 | - | $231.30 K(-54.5%) |
| Mar 2019 | - | $508.30 K(-12.1%) |
| Dec 2018 | $578.50 K(+139.1%) | $578.50 K(-54.3%) |
| Sep 2018 | - | $1.27 M(+197.1%) |
| Jun 2018 | - | $426.00 K(+374.9%) |
| Mar 2018 | - | $89.70 K(-62.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $241.90 K(-67.1%) | $241.90 K(+278.0%) |
| Sep 2017 | - | $64.00 K(-55.7%) |
| Jun 2017 | - | $144.50 K(+1.0%) |
| Mar 2017 | - | $143.10 K(-80.5%) |
| Dec 2016 | $735.40 K(+135.0%) | $735.40 K(+36.5%) |
| Sep 2016 | - | $538.70 K(+7.2%) |
| Jun 2016 | - | $502.50 K(>+9900.0%) |
| Mar 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $313.00 K(+467.0%) | $313.00 K(-32.2%) |
| Sep 2015 | - | $461.60 K(+1365.4%) |
| Jun 2015 | - | $31.50 K(-90.5%) |
| Mar 2015 | - | $331.40 K(+500.4%) |
| Dec 2014 | $55.20 K(-90.2%) | $55.20 K(-91.2%) |
| Sep 2014 | - | $626.60 K(+716.9%) |
| Jun 2014 | - | $76.70 K(-75.2%) |
| Mar 2014 | - | $309.40 K(-45.3%) |
| Dec 2013 | $565.40 K(-84.3%) | $565.40 K(>+9900.0%) |
| Sep 2013 | - | $0.00(-100.0%) |
| Jun 2013 | - | $3.63 M(+2.2%) |
| Mar 2013 | - | $3.55 M(-1.1%) |
| Dec 2012 | $3.59 M(>+9900.0%) | $3.59 M(>+9900.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Dec 2010 | $196.90 K | $196.90 K |
FAQ
- What is BioRestorative Therapies annual total long term liabilities?
- What is the all time high annual total long term liabilities for BioRestorative Therapies?
- What is BioRestorative Therapies annual total long term liabilities year-on-year change?
- What is BioRestorative Therapies quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly long term liabilities year-on-year change?
What is BioRestorative Therapies annual total long term liabilities?
The current annual total long term liabilities of BRTX is $0.00
What is the all time high annual total long term liabilities for BioRestorative Therapies?
BioRestorative Therapies all-time high annual total long term liabilities is $4.63 M
What is BioRestorative Therapies annual total long term liabilities year-on-year change?
Over the past year, BRTX annual total long term liabilities has changed by -$162.30 K (-100.00%)
What is BioRestorative Therapies quarterly total long term liabilities?
The current quarterly long term liabilities of BRTX is $0.00
What is the all time high quarterly long term liabilities for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly total long term liabilities is $15.17 M
What is BioRestorative Therapies quarterly long term liabilities year-on-year change?
Over the past year, BRTX quarterly total long term liabilities has changed by -$42.40 K (-100.00%)